Literature DB >> 22928786

Cavernous antioxidant effect of green tea, epigallocatechin-3-gallate with/without sildenafil citrate intake in aged diabetic rats.

T Mostafa1, D Sabry, A M Abdelaal, I Mostafa, M Taymour.   

Abstract

This study aimed to assess the cavernous antioxidant effect of green tea (GT), epigallocatechin-3-gallate (EGCG) with/without sildenafil citrate intake in aged diabetic rats. One hundred and four aged male white albino rat were divided into controls that received ordinary chow, streptozotocin (STZ)-induced aged diabetic rats, STZ-induced diabetic rats on infused green tea, induced diabetic rats on epigallocatechin-3-gallate and STZ-induced diabetic rats on sildenafil citrate added to EGCG. After 8 weeks, dissected cavernous tissues were assessed for gene expression of eNOS, cavernous malondialdehyde (MDA), glutathione peroxidase (GPx), cyclic guanosine monophosphate (cGMP), and serum testosterone (T). STZ-induced diabetic rats on GT demonstrated significant increase in cavernous eNOS, cGMP, GPx and significant decrease in cavernous MDA compared with diabetic rats. Diabetic rats on EGCG demonstrated significant increase in cavernous eNOS, cGMP, GPx and significant decrease in cavernous MDA compared with diabetic rats or diabetic rats on GT. Diabetic rats on EGCG added to sildenafil showed significant increase in cavernous eNOS, cGMP and significant decrease in cavernous MDA compared with other groups. Serum T demonstrated nonsignificant difference between the investigated groups. It is concluded that GT and EGCG have significant cavernous antioxidant effects that are increased if sildenafil is added.
© 2012 Blackwell Verlag GmbH.

Entities:  

Keywords:  Diabetes; epigallocatechin-3-gallate; green tea; oxidative stress; sildenafil; testosterone

Mesh:

Substances:

Year:  2012        PMID: 22928786     DOI: 10.1111/and.12005

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  5 in total

1.  Effects of prolonged ingestion of epigallocatechin gallate on diabetes type 1-induced vascular modifications in the erectile tissue of rats.

Authors:  C Lombo; C Morgado; I Tavares; D Neves
Journal:  Int J Impot Res       Date:  2016-05-12       Impact factor: 2.896

Review 2.  Molecular mechanisms associated with diabetic endothelial-erectile dysfunction.

Authors:  Ângela Castela; Carla Costa
Journal:  Nat Rev Urol       Date:  2016-02-16       Impact factor: 14.432

Review 3.  Diabetes Mellitus and Alzheimer's Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models.

Authors:  Jin-Jing Jia; Xian-Si Zeng; Xin-Qiang Song; Peng-Peng Zhang; Lei Chen
Journal:  Front Pharmacol       Date:  2017-11-16       Impact factor: 5.810

4.  Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway.

Authors:  Dong Chen; Ke-Qin Zhang; Bo Li; Ding-Qi Sun; Hui Zhang; Qiang Fu
Journal:  Asian J Androl       Date:  2017 May-Jun       Impact factor: 3.285

5.  Protective Effects of Epigallocatechin Gallate for Male Sexual Dysfunction in Streptozotocin-Induced Diabetic Rats.

Authors:  Andy C Huang; Ta-Chuan Yeh; Nien-Chin Wu; Chien-Yu Yeh; Pei-Hua Lin; Kuei-Ying Yeh
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.